• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢良性及交界性透明细胞腺纤维瘤

Benign and borderline clear cell adenofibromas of the ovary.

作者信息

Bell D A, Scully R E

出版信息

Cancer. 1985 Dec 15;56(12):2922-31. doi: 10.1002/1097-0142(19851215)56:12<2922::aid-cncr2820561233>3.0.co;2-l.

DOI:10.1002/1097-0142(19851215)56:12<2922::aid-cncr2820561233>3.0.co;2-l
PMID:4052962
Abstract

The criteria for the diagnosis of benign and borderline clear cell adenofibromas and their biologic behavior were investigated by examination of the clinical and pathologic features of 18 tumors in these categories. Three tumors that showed no significant epithelial atypicality were classified as benign. Twelve tumors that contained glands or small solid nests composed of epithelial cells with nuclear characteristics of low-grade malignancy without invasion of the stromal component of the tumor were designated as borderline. Three predominantly borderline tumors with focal microinvasion of the stromal component were also studied. The 17 patients had nonspecific complaints. Sixteen of the tumors were unilateral without surface involvement; one patient had bilateral borderline tumors. Most of the women were treated by hysterectomy and bilateral salpingo-oophorectomy. Follow-up information was available for 16 of the 17 patients. No recurrences or deaths from tumor occurred in 14 patients (2 benign, 10 borderline, 2 microinvasive). One patient with a borderline adenofibroma had questionable lung metastasis 4 years after presentation, and another patient who had a microinvasive tumor had a pelvic recurrence 3.3 years postoperatively.

摘要

通过检查18例此类肿瘤的临床和病理特征,研究了良性及交界性透明细胞腺纤维瘤的诊断标准及其生物学行为。3例无明显上皮异型性的肿瘤被分类为良性。12例肿瘤含有由具有低级别恶性核特征的上皮细胞组成的腺体或小实性巢,且未侵犯肿瘤的间质成分,被指定为交界性。还研究了3例主要为交界性且有局灶性间质微浸润的肿瘤。17例患者有非特异性主诉。16例肿瘤为单侧,未累及表面;1例患者有双侧交界性肿瘤。大多数女性接受了子宫切除术和双侧输卵管卵巢切除术。17例患者中有16例有随访信息。14例患者(2例良性、10例交界性、2例微浸润性)无肿瘤复发或死亡。1例交界性腺纤维瘤患者在就诊4年后有可疑的肺转移,另1例有微浸润性肿瘤的患者在术后3.3年出现盆腔复发。

相似文献

1
Benign and borderline clear cell adenofibromas of the ovary.卵巢良性及交界性透明细胞腺纤维瘤
Cancer. 1985 Dec 15;56(12):2922-31. doi: 10.1002/1097-0142(19851215)56:12<2922::aid-cncr2820561233>3.0.co;2-l.
2
Atypical and borderline endometrioid adenofibromas of the ovary. A report of 27 cases.卵巢非典型和交界性子宫内膜样腺纤维瘤。27例报告。
Am J Surg Pathol. 1985 Mar;9(3):205-14. doi: 10.1097/00000478-198503000-00004.
3
Benign clear cell adenofibroma of the ovary. A case report with literature review.卵巢良性透明细胞腺纤维瘤。一例病例报告并文献复习。
Gynecol Obstet Invest. 2007;64(1):36-9. doi: 10.1159/000098425. Epub 2007 Jan 5.
4
Mucinous adenofibromas of the ovary. A report of 10 cases.
Am J Surg Pathol. 1991 Mar;15(3):227-32. doi: 10.1097/00000478-199103000-00003.
5
Endometrioid proliferative and low malignant potential tumors of the ovary. A clinicopathologic study of 46 cases.卵巢子宫内膜样增生性及低恶性潜能肿瘤:46例临床病理研究
Am J Surg Pathol. 1988 Sep;12(9):661-71. doi: 10.1097/00000478-198809000-00002.
6
A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary.卵巢非典型增生性(交界性)肿瘤及高分化子宫内膜样腺癌的临床病理分析
Am J Surg Pathol. 2000 Nov;24(11):1465-79. doi: 10.1097/00000478-200011000-00002.
7
Ovarian Clear Cell Adenofibroma of Low Malignant Potential Developing Into Clear Cell Adenocarcinoma.具有低度恶性潜能的卵巢透明细胞腺纤维瘤发展为透明细胞腺癌
Int J Surg Pathol. 2018 Sep;26(6):578-580. doi: 10.1177/1066896918763547. Epub 2018 Mar 19.
8
Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma.苗勒管腺肉瘤:一项对55例病例的临床病理及免疫组化研究,对腺纤维瘤的存在提出质疑。
Am J Surg Pathol. 2009 Feb;33(2):278-88. doi: 10.1097/PAS.0b013e318181a80d.
9
Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases.伴有间质微浸润的卵巢浆液性交界性肿瘤:21例报告
Hum Pathol. 1990 Apr;21(4):397-403. doi: 10.1016/0046-8177(90)90201-f.
10
Conservative treatment of borderline ovarian tumors.卵巢交界性肿瘤的保守治疗
Obstet Gynecol. 1985 Sep;66(3):417-22.

引用本文的文献

1
Clear Cell Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Management.
Ann Surg Oncol. 2022 Feb;29(2):1165-1170. doi: 10.1245/s10434-021-10776-7. Epub 2021 Oct 1.
2
Clear cell borderline tumor without fibromatous component: Pathological and literature review and report of two cases.无纤维瘤成分的透明细胞交界性肿瘤:病理及文献复习并附两例报告
Mol Clin Oncol. 2021 Apr;14(4):75. doi: 10.3892/mco.2021.2237. Epub 2021 Feb 23.
3
[Pitfalls and common problems in the differential diagnosis of epithelial ovarian tumors].[上皮性卵巢肿瘤鉴别诊断中的陷阱与常见问题]
Pathologe. 2019 Feb;40(1):46-60. doi: 10.1007/s00292-019-0572-9.
4
Primary Ovarian Clear Cell Adenofibroma of Borderline Malignancy.交界性原发性卵巢透明细胞腺纤维瘤
Oman Med J. 2012 Jan;27(1):e031. doi: 10.5001/omj.2012.20.
5
Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria.2014年世界卫生组织分类中的卵巢交界性肿瘤:不断演变的概念和诊断标准
Virchows Arch. 2017 Feb;470(2):125-142. doi: 10.1007/s00428-016-2040-8. Epub 2016 Dec 27.
6
Clear Cell Adenocarcinoma Arising from Adenofibroma in a Patient with Endometriosis of the Ovary.卵巢子宫内膜异位症患者腺纤维瘤发生的透明细胞腺癌
J Pathol Transl Med. 2016 Mar;50(2):155-9. doi: 10.4132/jptm.2015.08.07. Epub 2015 Oct 26.
7
Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development.卵巢透明细胞腺纤维瘤、非典型增生(交界性)肿瘤和癌的发病机制:具有子宫内膜异位症或腺纤维瘤成分的肿瘤的临床病理特征支持肿瘤发展的两种相关途径。
J Cancer. 2011 Feb 21;2:94-106. doi: 10.7150/jca.2.94.
8
Acute presentation of a benign cystadenofibroma of the fallopian tube: a case report.输卵管良性囊腺纤维瘤的急性表现:一例病例报告
J Med Case Rep. 2010 Jun 17;4:181. doi: 10.1186/1752-1947-4-181.
9
Aberrant expression of p27(Kip1)-interacting cell-cycle regulatory proteins in ovarian clear cell carcinomas and their precursors with special consideration of two distinct multistage clear cell carcinogenetic pathways.卵巢透明细胞癌及其前体中 p27(Kip1)-相互作用细胞周期调节蛋白的异常表达,并特别考虑两种不同的多步骤透明细胞癌发生途径。
Virchows Arch. 2009 Nov;455(5):413-22. doi: 10.1007/s00428-009-0844-5. Epub 2009 Oct 24.
10
An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathway.一项等位基因型分析表明存在两种不同的卵巢透明细胞癌致癌途径:子宫内膜异位症相关途径与透明细胞腺纤维瘤相关途径。
Virchows Arch. 2009 Sep;455(3):261-70. doi: 10.1007/s00428-009-0816-9. Epub 2009 Aug 5.